FRIBA Investment
VC Fund
FRIBA Investment is a VC fund focused on Biotechnology and Solar. A German Single Family Office
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries FRIBA Investment invests in
Stages FRIBA Investment invests in
Countries FRIBA Investment invests in
Investment Focus
Industry
- Biotechnology 2 (40%)
- Solar 1 (20%)
- Energy 1 (20%)
- Software 1 (20%)
- Biopharma 1 (20%)
Stage
- Seed 1 (20%)
- Series A 1 (20%)
- Series B 1 (20%)
- Series C 1 (20%)
- Private Equity 1 (20%)
Country
- Germany 3 (60%)
- Switzerland 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
4.screen
|
4.screen is a technology company that develops technologies for driver interactions. The 4.screen Mobility Experience Cloud (MXC) connects the car to the mobility ecosystem and provides a standardized interface for real-time communication with drivers. 4.screen shares a common goal with car manufacturers and businesses – placing the driver at thecenter of every equation. Car manufacturers and mobility service providers implement 4.screen APIs into their existing systems and applications to provide integrated services for seamless journeys. Businesses of all sizes - from local shops to global brands - use 4.screen to communicate with drivers directly through the vehicle's screen. Drivers enjoy frictionless access to the mobility ecosystem, see more relevant content and benefit from value-added services such as sponsored parking and charging. The 4.screen technology is developed by a team of automotive, marketing, and software experts who are committed to creating seamless experiences for drivers. | $21M / Series B / Jul 22, 2025 | |
|
4.screen
|
4.screen is a technology company that develops technologies for driver interactions. The 4.screen Mobility Experience Cloud (MXC) connects the car to the mobility ecosystem and provides a standardized interface for real-time communication with drivers. 4.screen shares a common goal with car manufacturers and businesses – placing the driver at thecenter of every equation. Car manufacturers and mobility service providers implement 4.screen APIs into their existing systems and applications to provide integrated services for seamless journeys. Businesses of all sizes - from local shops to global brands - use 4.screen to communicate with drivers directly through the vehicle's screen. Drivers enjoy frictionless access to the mobility ecosystem, see more relevant content and benefit from value-added services such as sponsored parking and charging. The 4.screen technology is developed by a team of automotive, marketing, and software experts who are committed to creating seamless experiences for drivers. | $23M / Series A / Apr 04, 2023 | |
Enpal
|
Enpal is a photovoltaics leasing firm that provides solar power systems. Its product already enables customers to reduce their electricity expenditure through a solar system and a green all-inclusive energy solution. The company was founded in 2017 by Jochen Ziervogel, Mario Kohle, and Viktor Wingert. It is based in Berlin, Germany. | $118.5M / Series C / Jul 08, 2021 | |
Isotopen Technologien München
|
ITM Isotopen Technologien München AG is a privately held biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radionuclides for use in cancer treatment. Since its foundation in 2004, ITM and its subsidiaries haveestablished GMP manufacturing and a robust global supply network of a novel, first-in-class medical radionuclides and -generator platform for a new generation of targeted cancer diagnostics and therapies. ITM’s isotope business is profitable and growing. In July 2016 the European Commission has granted Marketing Authorization for EndolucinBeta® of ITM´s subsidiary ITG Isotope Technologies Garching GmbH. EndolucinBeta® respectively no-carrier-added (n.c.a.) Lutetium (177Lu) chloride is a radiopharmaceutical precursor and is used in Targeted Radionuclide Therapy. The drug approval is an important milestone for ITM as a specialized radiopharmaceutical company.Furthermore, ITM is developing a proprietary portfolio and growing pipeline of targeted treatments in various stages of clinical development, which address a range of cancers such as neuroendocrine cancers or bone metastases. ITM’s main objectives, together with its scientific, medical and industrial collaboration partners worldwide, are to significantly improve outcomes and quality of life for cancer patients while at the same time reducing side effects and improving health economics through a new generation of Targeted Radionuclide Therapies in Precision Oncology. | $30.4M / Private Equity / Jun 10, 2021 | |
MIRAI FOODS
|
Mirai Foods is a cellular agriculture startup developing cultured beef. | $4.5M / Seed / Mar 15, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does FRIBA Investment invest in?
FRIBA Investment invests primarily in Biotechnology, Solar and Energy startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did FRIBA Investment last invest?
The most recent investment recorded for FRIBA Investment closed in Jul 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
